Literature DB >> 33400352

Prioritization of Patients with Abnormal Breast Findings in the Alerta Rosa Navigation Program to Reduce Diagnostic Delays.

Jaime Tamez-Salazar1,2, Teresa Mireles-Aguilar1,2, Cynthia de la Garza-Ramos2, Marisol Garcia-Garcia2, Ana S Ferrigno2, Alejandra Platas1, Cynthia Villarreal-Garza1,2.   

Abstract

INTRODUCTION: In Mexico, there are considerable health system delays in the diagnosis and treatment initiation of women with breast cancer. Alerta Rosa is a navigation program in Nuevo Leon that aims to reduce barriers that impede the timely management of these patients. PATIENTS AND METHODS: Since December 2017, women who registered to receive medical evaluations by Alerta Rosa were stratified based on their clinical characteristics into three priority groups ("Red," "Yellow," and "Green"). According to the category assigned, patients were scheduled imaging studies and medical appointments with breast specialists on a preferential basis.
RESULTS: Up until December 2019, 561 patients were scheduled for medical evaluations. Of them, 59% were classified as "Red," 25% "Yellow," and 16% "Green" priority. The median time from stratification to first medical evaluation was 4, 6, and 7 days, respectively (p = .003). Excluding those who had a prior breast cancer diagnosis, 21 patients were diagnosed by Alerta Rosa, with the initial "Red" priority classification demonstrating a sensitivity of 95% (95% confidence interval [CI], 75.1%-99.9%) and specificity of 42% (95% CI, 37.1%-47.1%) for breast cancer. The median time elapsed from initial patient contact to diagnosis and treatment initiation was 16 days and 39 days, respectively. The majority (72%) of patients were diagnosed at an early stage (0-II).
CONCLUSION: This patient prioritization system adequately identified women with different probabilities of having breast cancer. Efforts to replicate similar triage systems in resource-constrained settings where screening programs are ineffective could prove to be beneficial in reducing diagnostic intervals and achieving early-stage diagnoses. IMPLICATIONS FOR PRACTICE: Low- and middle-income countries such as Mexico currently lack the infrastructure to achieve effective breast cancer screening and guarantee prompt access to health care when required. To reduce the disease burden in such settings, strategies targeting early detection are urgently needed. Patient navigation programs aid in the reduction of health system intervals and optimize the use of available resources. This article presents the introduction of a triage system based on initial patient concern. Appointment prioritization proved to be successful at reducing health system intervals and achieving early-stage diagnoses by overcoming barriers that impede early access to quality medical care.
© 2020 AlphaMed Press.

Entities:  

Keywords:  Breast cancer; Health system delays; Mexico; Navigation; Triage

Mesh:

Year:  2020        PMID: 33400352      PMCID: PMC7938393          DOI: 10.1634/theoncologist.2020-0228

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  23 in total

1.  The evolution of breast cancer navigation and survivorship care.

Authors:  Lillie D Shockney
Journal:  Breast J       Date:  2014-11-13       Impact factor: 2.431

2.  Breast cancer in limited-resource countries: health care systems and public policy.

Authors:  Benjamin O Anderson; Cheng-Har Yip; Scott D Ramsey; Rafael Bengoa; Susan Braun; Margaret Fitch; Martijn Groot; Helene Sancho-Garnier; Vivien D Tsu
Journal:  Breast J       Date:  2006 Jan-Feb       Impact factor: 2.431

Review 3.  Challenges to the early diagnosis and treatment of breast cancer in developing countries.

Authors:  Karla Unger-Saldaña
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  [Utilization patterns of prevention and early diagnosis for cancer in women].

Authors:  Gabriela Torres-Mejía; Carolina Ortega-Olvera; Angélica Ángeles-Llerenas; Aremis Litai Villalobos-Hernández; Jorge Salmerón-Castro; Eduardo Lazcano-Ponce; Mauricio Hernández-Ávila
Journal:  Salud Publica Mex       Date:  2013

5.  The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: A systematic review.

Authors:  Brittany M Bernardo; Xiaochen Zhang; Chloe M Beverly Hery; Rachel J Meadows; Electra D Paskett
Journal:  Cancer       Date:  2019-04-29       Impact factor: 6.860

6.  The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico.

Authors:  Kristin Bright; Maya Barghash; Martin Donach; Marcos Gutiérrez de la Barrera; Robert J Schneider; Silvia C Formenti
Journal:  Breast       Date:  2011-03-02       Impact factor: 4.380

7.  Alerta Rosa: Novel Alert and Navigation Breast Cancer Program in Nuevo Leon, Mexico, for Reducing Health System Interval Delays.

Authors:  Teresa Mireles-Aguilar; Jaime Tamez-Salazar; Jose F Muñoz-Lozano; Edna A Lopez-Martinez; Cristina Romero; Alejandra Platas; Cynthia Villarreal-Garza
Journal:  Oncologist       Date:  2018-08-20

8.  Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016.

Authors:  Rajesh Sharma
Journal:  Breast Cancer       Date:  2019-01-02       Impact factor: 4.239

9.  Nurse Navigation Program: Outcomes From a Breast Cancer Center in Brazil.

Authors:  Vania Rohsig; Poliana Silva; Rosane Teixeira; Elisiane Lorenzini; Rubia Maestri; Taiana Saraiva; Aline Souza
Journal:  Clin J Oncol Nurs       Date:  2019-02-01       Impact factor: 1.027

10.  Health system delay and its effect on clinical stage of breast cancer: Multicenter study.

Authors:  Karla Unger-Saldaña; Alfonso Miranda; Gelasio Zarco-Espinosa; Fernando Mainero-Ratchelous; Enrique Bargalló-Rocha; Jesús Miguel Lázaro-León
Journal:  Cancer       Date:  2015-03-24       Impact factor: 6.860

View more
  1 in total

Review 1.  Coordination Models for Cancer Care in Low- and Middle-Income Countries: A Scoping Review.

Authors:  Buhle Lubuzo; Khumbulani W Hlongwana; Mbuzeleni Hlongwa; Themba G Ginindza
Journal:  Int J Environ Res Public Health       Date:  2022-06-28       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.